Appleton Partners’s SteadyMed Ltd STDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-20,950
Closed -$99K 286
2019
Q1
$99K Hold
20,950
0.01% 259
2018
Q4
$99K Sell
20,950
-1,185
-5% -$5.6K 0.01% 251
2018
Q3
$105K Hold
22,135
0.01% 258
2018
Q2
$100K Buy
+22,135
New +$90.3K 0.01% 259

Appleton Partners's STDY Position: Q2 2019 in Review

Appleton Partners sold out of SteadyMed Ltd (STDY) in Q2 2019, closing a stake of 20,950 shares — an estimated $99K sold.

Appleton Partners first reported a position in STDY in Q2 2018 and held it in 4 quarters. The position peaked at $105K in Q3 2018. 0 funds tracked by Wall St. Rank hold STDY as of Q2 2019.

  • Appleton Partners reported no remaining SteadyMed Ltd position as of Q2 2019 after selling out during the quarter.
  • Appleton Partners sold 20,950 SteadyMed Ltd shares in Q2 2019, an estimated $99K.
  • Appleton Partners first reported a position in SteadyMed Ltd in Q2 2018 and held it in 4 quarters.
  • Appleton Partners's SteadyMed Ltd position peaked at $105K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2019.

Based on Appleton Partners's 13F filing for Q2 2019, filed 25 Jul 2019.